Search results
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters via Yahoo News· 5 days agoModerna told Reuters it was in discussions with the government on advancing its vaccine candidate,...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 1 day agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 4 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
Why Moderna Stock Is Sinking This Week
Motley Fool via Yahoo Finance· 5 days agoShares of Moderna (NASDAQ: MRNA) were sinking 9% lower this week as of Thursday's market close, according to data provided by S&P Global Market...
FDA approves Moderna's RSV vaccine, its second marketed product
USA TODAY via Yahoo News· 4 days agoThe U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus vaccine, the company announced on Friday, giving it a shot at much-needed new revenue ...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 18 hours agoInsights from TIME, The Washington Post, MIT Technology Review The News Pharmaceutical giants ...
Moderna director Noubar Afeyan sells shares worth over $2.9 million By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a total of $2,901,584 worth of company...
Why Moderna Stock Is Sinking This Week | The Motley Fool
The Motley Fool· 5 days agoShares of Moderna (MRNA 2.41%) were sinking 9% lower this week as of Thursday's market close,...
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 4 days agoThe Food and Drug Administration on Friday approved Moderna's vaccine for respiratory syncytial...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 4 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
